NAD+ science, now formulated for skin | Discover Niagen Skincare Innovation Lab

New Clinical Study Explores Tru Niagen's Role in Long COVID Symptom Management

ChromaDex is now Niagen Bioscience

NAD+ science, now formulated for skin | Discover Niagen Skincare Innovation Lab

New Clinical Study Explores Tru Niagen's Role in Long COVID Symptom Management

ChromaDex is now Niagen Bioscience

Skip to content

Niagen Bioscience | The Leading NAD+ Science and Research Company | There's a Better Way to Age

About
Niagen Brands
Ingredients
Reference Standards
Science
Investor Relations
News

Niagen Bioscience | The Leading NAD+ Science and Research Company | There's a Better Way to Age

About
Our Company
Leadership
Contact
Niagen Brands
Niagen Brands
Tru Niagen®
Niagen® Plus
Ingredients
Niagen®
Other Ingredients
Patents
Reference Standards
Science
Quality and Transparency
Science Leadership
Niagen Research Program
Clinical Studies
Skincare Innovation Lab
Investor Relations
News

About
- About
- Our Company
- Leadership
- Contact
Niagen Brands
Ingredients
Reference Standards
Science
Investor Relations
News

Register / Login

News

Resources

About
Contact Us
Careers
News

Our Company

Niagen Brands
Niagen® Ingredient
Other Ingredients
Reference Standards
Investor Relations
CERP

BRANDS

Tru Niagen®
Niagen® Plus
Your Privacy Choices

Follow Us

NASDAQ: NAGE

© 2026 Niagen Bioscience. All rights reserved.

Patent
Privacy Policy
Consumer Health Data Privacy
CA Privacy
Terms
Accessibility
Compliance

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Based on registered ongoing or completed clinical trials under "nicotinamide riboside" on clinicaltrials.gov.
Based on revenue per largest U.S. e-commerce marketplace (Jan-Dec 2024)

Availability

PP-DEBUG: Current path: /blogs/news

This page is protected, On the actual website the customers will see the protection overlay on this page.

Password Required

Please enter the password to access this page.